138 related articles for article (PubMed ID: 36410168)
21. Discovery of novel diphenylbutene derivative ferroptosis inhibitors as neuroprotective agents.
Fang Y; Tan Q; Zhou H; Gu Q; Xu J
Eur J Med Chem; 2022 Mar; 231():114151. PubMed ID: 35123296
[TBL] [Abstract][Full Text] [Related]
22. Ferroptosis-related small-molecule compounds in cancer therapy: Strategies and applications.
Yin L; Liu P; Jin Y; Ning Z; Yang Y; Gao H
Eur J Med Chem; 2022 Dec; 244():114861. PubMed ID: 36332549
[TBL] [Abstract][Full Text] [Related]
23. System Xc
Liu MR; Zhu WT; Pei DS
Invest New Drugs; 2021 Aug; 39(4):1123-1131. PubMed ID: 33506324
[TBL] [Abstract][Full Text] [Related]
24. Discovery of 2-vinyl-10H-phenothiazine derivatives as a class of ferroptosis inhibitors with minimal human Ether-a-go-go related gene (hERG) activity for the treatment of DOX-induced cardiomyopathy.
You J; Yang W; Ma R; Xia A; Zhang G; Fang Z; Guo N; Yang S; Li L
Bioorg Med Chem Lett; 2022 Oct; 74():128911. PubMed ID: 35907606
[TBL] [Abstract][Full Text] [Related]
25. Ferroptosis, a new form of cell death, and its relationships with tumourous diseases.
Yu H; Guo P; Xie X; Wang Y; Chen G
J Cell Mol Med; 2017 Apr; 21(4):648-657. PubMed ID: 27860262
[TBL] [Abstract][Full Text] [Related]
26. Ferroptosis Promotes Photodynamic Therapy: Supramolecular Photosensitizer-Inducer Nanodrug for Enhanced Cancer Treatment.
Zhu T; Shi L; Yu C; Dong Y; Qiu F; Shen L; Qian Q; Zhou G; Zhu X
Theranostics; 2019; 9(11):3293-3307. PubMed ID: 31244955
[TBL] [Abstract][Full Text] [Related]
27. PGRMC1-dependent lipophagy promotes ferroptosis in paclitaxel-tolerant persister cancer cells.
You JH; Lee J; Roh JL
J Exp Clin Cancer Res; 2021 Nov; 40(1):350. PubMed ID: 34749765
[TBL] [Abstract][Full Text] [Related]
28. SHP-1/STAT3-Signaling-Axis-Regulated Coupling between BECN1 and SLC7A11 Contributes to Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma.
Huang CY; Chen LJ; Chen G; Chao TI; Wang CY
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232407
[TBL] [Abstract][Full Text] [Related]
29. Extracellular Concentration of L-Cystine Determines the Sensitivity to System x
Abdullah M; Lee SJ
Biomol Ther (Seoul); 2022 Mar; 30(2):184-190. PubMed ID: 34667132
[TBL] [Abstract][Full Text] [Related]
30. Identification and initial characterization of a potent inhibitor of ferroptosis.
Kuganesan N; Dlamini S; McDaniel J; Tillekeratne VLM; Taylor WR
J Cell Biochem; 2021 Apr; 122(3-4):413-424. PubMed ID: 33377232
[TBL] [Abstract][Full Text] [Related]
31. Patulin disrupts SLC7A11-cystine-cysteine-GSH antioxidant system and promotes renal cell ferroptosis both in vitro and in vivo.
Chen H; Cao L; Han K; Zhang H; Cui J; Ma X; Zhao S; Zhao C; Yin S; Fan L; Hu H
Food Chem Toxicol; 2022 Aug; 166():113255. PubMed ID: 35772596
[TBL] [Abstract][Full Text] [Related]
32. Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells.
Rademaker G; Boumahd Y; Peiffer R; Anania S; Wissocq T; Liégeois M; Luis G; Sounni NE; Agirman F; Maloujahmoum N; De Tullio P; Thiry M; Bellahcène A; Castronovo V; Peulen O
Redox Biol; 2022 Jul; 53():102324. PubMed ID: 35533575
[TBL] [Abstract][Full Text] [Related]
33. ATF3 promotes erastin-induced ferroptosis by suppressing system Xc
Wang L; Liu Y; Du T; Yang H; Lei L; Guo M; Ding HF; Zhang J; Wang H; Chen X; Yan C
Cell Death Differ; 2020 Feb; 27(2):662-675. PubMed ID: 31273299
[TBL] [Abstract][Full Text] [Related]
34. Platelet-Vesicles-Encapsulated RSL-3 Enable Anti-Angiogenesis and Induce Ferroptosis to Inhibit Pancreatic Cancer Progress.
Zhang Y; Huang Z; Cheng J; Pan H; Lin T; Shen X; Chen W; Chen Q; Gu C; Mao Q; Liang Y
Front Endocrinol (Lausanne); 2022; 13():865655. PubMed ID: 35399954
[TBL] [Abstract][Full Text] [Related]
35. Ferroptosis: An emerging therapeutic opportunity for cancer.
Wang L; Chen X; Yan C
Genes Dis; 2022 Mar; 9(2):334-346. PubMed ID: 35224150
[TBL] [Abstract][Full Text] [Related]
36. Activation of the reverse transsulfuration pathway through NRF2/CBS confers erastin-induced ferroptosis resistance.
Liu N; Lin X; Huang C
Br J Cancer; 2020 Jan; 122(2):279-292. PubMed ID: 31819185
[TBL] [Abstract][Full Text] [Related]
37. Ferroptosis inducer erastin downregulates androgen receptor and its splice variants in castration‑resistant prostate cancer.
Yang Y; Liu T; Hu C; Xia H; Liu W; Chen J; Wu S; Jiang Y; Xu Y; Liu W; Zhao L
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649848
[TBL] [Abstract][Full Text] [Related]
38. Design and synthesis of novel benzimidazole derivatives as anti-tuberculosis agents.
Zhang HY; Wang B; Sheng L; Li D; Zhang DF; Lin ZY; Lu Y; Li Y; Huang HH
Yao Xue Xue Bao; 2014 May; 49(5):644-51. PubMed ID: 25151735
[TBL] [Abstract][Full Text] [Related]
39. System X
Li FJ; Long HZ; Zhou ZW; Luo HY; Xu SG; Gao LC
Front Pharmacol; 2022; 13():910292. PubMed ID: 36105219
[TBL] [Abstract][Full Text] [Related]
40. Blockade of GCH1/BH4 Axis Activates Ferritinophagy to Mitigate the Resistance of Colorectal Cancer to Erastin-Induced Ferroptosis.
Hu Q; Wei W; Wu D; Huang F; Li M; Li W; Yin J; Peng Y; Lu Y; Zhao Q; Liu L
Front Cell Dev Biol; 2022; 10():810327. PubMed ID: 35223839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
